Clinical Trials Logo

Depression clinical trials

View clinical trials related to Depression.

Filter by:

NCT ID: NCT03553095 Active, not recruiting - Depression Clinical Trials

Comparing Inflammatory Markers in Patients With and Without Depression With Chronic Periodontitis

Start date: July 12, 2018
Phase: N/A
Study type: Interventional

This study will evaluate whether use of antidepressants can reduce gingival inflammation in patients with periodontal (gum) disease.

NCT ID: NCT03540745 Active, not recruiting - Depression Clinical Trials

Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders

Start date: June 11, 2018
Phase: N/A
Study type: Interventional

The purpose of this research study is to determine whether Nexalin Trans-cranial Electrical Stimulation (TES) is a viable adjunctive treatment of substance use treatments.

NCT ID: NCT03519451 Active, not recruiting - Depression Clinical Trials

Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation Treatment

Start date: April 25, 2018
Phase: N/A
Study type: Interventional

This trial studies how well smartphone mobile applications work in enhancing smoking cessation treatment in current smokers. Smartphone mobile applications may help current smokers quit smoking.

NCT ID: NCT03496675 Active, not recruiting - Depression Clinical Trials

Music Interventions for Dementia and Depression in Elderly Care

MIDDEL
Start date: July 18, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effectiveness of two music-based approaches - group music therapy and recreational choir singing - for reducing depression symptoms in people living with dementia. It also examines mechanisms and heterogeneity of treatment effects.

NCT ID: NCT03484754 Active, not recruiting - Major Depression Clinical Trials

Infiltrations of OnaBotulinum Toxin A in Resistant Depression: Comparison of Two Facial Injection Sites.

OnaDEP
Start date: April 1, 2018
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate in adult subjects with resistant depression the effect of an injection of botulinum toxin in the corrugator and procerus muscles, in comparison to the infiltration of the crow's feet area, in addition to the current antidepressant treatment.

NCT ID: NCT03484494 Active, not recruiting - Bipolar Disorder Clinical Trials

Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression

LFMSBioMGeri
Start date: May 29, 2018
Phase: N/A
Study type: Interventional

The protocol involves functional Magnetic Resonance Imaging acquisitions immediately before and after Low Field Magnetic Stimulation treatment on two separate days in a sham controlled, randomized trial, in order to assess the physiologic effects of Low Field Magnetic Stimulation on brain function in a geriatric population with bipolar depression.

NCT ID: NCT03480061 Active, not recruiting - Depression Clinical Trials

Dexmedetomidine to Reduce the Incidence of POCD After Open Cardiac Surgery

Start date: August 9, 2018
Phase: Phase 4
Study type: Interventional

Anesthesia is a drug induced, reversible, comatose state that facilitates surgery and it is widely assumed that cognition returns to baseline after anesthetics have been eliminated. However, many patients have persistent memory impairment for weeks to months after surgery. Cardiac surgery appears to carry the highest risk of postoperative cognitive dysfunction (POCD). These cognitive deficits are associated with increased mortality, prolonged hospital stay and loss of independence. The investigators propose to investigate the role of Dexmedetomidine (DEX) in preventing long-term POCD after cardiac surgery and enhancing early postoperative recovery. It is anticipated that DEX will be the first effective preventative therapy for POCD, improve patient outcomes, and reduce length of stay and healthcare costs.

NCT ID: NCT03472638 Active, not recruiting - Major Depression Clinical Trials

Dorsomedial rTMS For Depression In Borderline Personality Disorder

rTMS
Start date: July 2016
Phase: N/A
Study type: Interventional

This randomized trial with a crossover design will examine the efficacy of rTMS targeting the dorsomedial prefrontal cortex as a treatment for medication-resistant major depression in patients meeting diagnostic criteria for borderline personality disorder.

NCT ID: NCT03451630 Active, not recruiting - Hypertension Clinical Trials

PCORI Integrated Care (IC) Models for Patient-Centered Outcomes

IC
Start date: April 23, 2018
Phase: N/A
Study type: Interventional

Multiple chronic conditions (MCC) are widely recognized as the U.S. public health challenge of the 21st century. These physical and behavioral health conditions take a large toll on those suffering from the diseases, including many who are publicly insured, as well as caregivers and society. While evidence-based integrated care models can improve outcomes for individuals with MCC, such models have not yet been widely implemented. Insurance providers/payers have innovative system features that can be used to deploy these models; however, the investigators do not yet know which of these features can best help to improve outcomes for individuals with MCC in general or high-need subgroups in particular. As a result, patients lack information to make important decisions about their health and health care, and system-level decision makers face ongoing challenges in effectively and efficiently supporting those with MCC. This real-world study will provide useful information about available options for supporting individuals with MCC. Building on existing integrated care efforts, the investigators will enroll N=1,927 (N=265 Phase I and N=1,662 Phase II) adults with MCC at risk for repeated hospitalizations and assess the impact of three payer-led options (e.g. High-Touch, High-Tech, Usual Care) on patient-centered outcomes, namely patient activation in health care, health status, and subsequent re-hospitalization. The investigators will also determine which option works best for whom under what circumstances by gathering information directly from individuals with MCC through self-report questionnaires, health care use data, and interviews.

NCT ID: NCT03448523 Active, not recruiting - Depression Clinical Trials

Evaluation of Right To Play's Positive Child and Youth Development Program in Middle Schools in Hyderabad, Pakistan

Start date: December 1, 2015
Phase: N/A
Study type: Interventional

This is a RCT conducted with 1752 children in 40 public middle schools in Hyderabad Pakistan with the goal of evaluating the effectiveness of the international non-governmental organisation Right To Play's Positive Child and Youth Development program on reducing peer violence perpetration and victimisation and child depression in a two arm trial where this intervention is compared to a no intervention arm.